Fierce Biotech Week brings together the industry’s top innovators, decision-makers, and visionaries driving the future of drug development, clinical research, business development and licensing, TMF, ...

It was as recently as February that biotech CEOs were talking enthusiastically to Fierce about a positive “shift in the ...

The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping takeover valuations, trailblazing innovation in battling obesity and cancer, ...

So, what will the early months of 2026 look like for the biotech sector? First, let me say that the biotech sector being 'en fuego' over the past three quarters has made my year as far as my portfolio ...

Biotech-based exchange-traded fund (“ETF”) iShares Biotechnology ETF IBB rallied 30.2% over the past six months (as of Oct. 15, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 26.5%). Year to date ...

Vishnu Tripathi develops reagents and assays to advance clinical care and research diagnostics.